Digital Pharma: New EMA website previewed

pharmafile | February 3, 2010 | News story | Research and Development, Sales and Marketing EMA, branding, digital pharma 

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information.

This will be cause for celebration for anyone who has found themselves lost within the labyrinthine turns of its current online home.

A sneak preview of the new EMA site was included in a short promotional film the agency recently put online to celebrate its first 15 years.

From this it looks like the site’s new features will include a medicines sections, a medicines search function and dedicated areas for patients, healthcare professionals and the pharmaceutical industry.

The site will go live at the EMA’s current online home www.ema.europa.eu, which it attracts more than 700,000 visits a month.

The online facelift is part of an ongoing re-branding exercise that has already seen Europe’s medicines regulator release its new ‘visual identity’ (it’s a pestle and mortar, since you ask).

Dominic Tyer is web editor for Pharmafocus and InPharm.com and the author of the Digital Pharma blog. He can be contacted via email, Twitter or LinkedIn.

Blog footer

Related Content

EC approves Pfizer’s Prevenar 20 to protect paediatric patients against pneumococcal disease

Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Prevenar 20, …

louis-reed-pwckf7l4-no-unsplash_5

EMA validates two applications for datopotamab deruxtecan for cancer treatments

AstraZeneca has announced that the European Medicines Agency (EMA) has validated to marketing authorisation applications …

AstraZeneca’s Voydeya recommended for approval in EU by CHMP

AstraZeneca has announced that Voydeya (danicopan) has been recommended for marketing authorisation in the European …

Latest content